A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A

Clinical trial NCT03814408 · UNKNOWN

Trial details

NCT number: NCT03814408
Sponsor: Rocket Pharmaceuticals Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Fanconi Anemia Complementation Group A

Start date: 2019-01-11
Primary completion: 2020-12-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.